Advertisement

Topics

Search Results for "Men Ejaculation Video"

01:30 EST 11th February 2016 | BioPortfolio

Matching Channels

Video capsule endoscopy

PolyXen

PolyXen® is an enabling technology for protein drug delivery.  It uses the natural polymer polysialic acid (PSA) to prolong the active life and improve the stability of therapeutic peptides...

ImuXen

ImuXen® is a liposomal technology platform designed to improve the delivery and effectiveness of DNA, protein and polysaccharide vaccines. Proof of concept preclinical studies with a number of...

Matching News

Advances in understanding and treating premature ejaculation

Our understanding of the epidemiology, pathophysiology, and management of premature ejaculation has increased substantially in recent years. Expert-agreed definitions of premat...

Premature ejaculation isn't a true illness

A new review argues that premature ejaculation—which has become the center of a multimillion dollar business—should not be classified as a male sexual dysfunction. By pointing to false assumptions...

Ixchelsis achieves positive clinical POC for IX-01 to treat premature ejaculation

UK biotechnology firm Ixchelsis has achieved positive clinical proof of concept (POC) for IX-01, its oral oxytocin receptor antagonist being developed to treat premature ejaculation (PE).

Is It Feasible and Clearly Beneficial to Combine Immunotherapy Approaches?

Drs. Leora Horn, Ben Solomon, & Jack West review the potential rationale and possible limitations of combining different immuntherapy strategies with one another.Related Posts:Promising Early Res...

What Is Next-Gen Sequencing?

Dr. Ed Kim from the Levine Cancer Institute in Charlotte, NC summarizes the mechanism of next generation sequencing (NGS), how it can potentially be used, and its limitations in clinical practice toda...

What is the Optimal Duration of Immunotherapy?

UCLA Med Center's Dr. Eddie Garon discusses the open question of the optimal duration of ongoing treatment with immunotherapy for lung cancer.Related Posts:Immunotherapy for Previously Treated Advance...

The Central Nervous System as a Sanctuary Site: The Special Case for Brain Metastases

Dr. Taofeek Owonikoko reviews why we often see brain metastases develop as a first or only site of progression in patients with

Immunotherapy for First Line Therapy of Advanced NSCLC

Dr. Eddie Garon considers the data on immunotherapies for first line treatment of advanced

Matching PubMed Articles

Comparing the length of penile mucosa in men with and without premature ejaculation.

Premature ejaculation is one of the prevalent disorders in men; almost one out of three men between 18 and 59 years old have this disorder with its leading sequel such as lack of self-confidence, anxi...

Pharmacotherapy for premature ejaculation.

Four premature ejaculation (PE) subtypes are distinguished on the basis of the duration of the intravaginal ejaculation latency time (IELT), its course in life, and frequency of complaints. Since the ...

Re: Simões Paço J, Jorge Pereira B. "New Therapeutic Perspectives in Premature Ejaculation". A rebuttal: premature ejaculation is not a male sexual dysfunction.

Association Between Changes in Serum 5-Hydroxy-Tryptamine Concentrations and Improvement in Clinical Symptoms in Primary Premature Ejaculation with Paroxetine Treatment.

BACKGROUND This study aimed to investigate the association between changes in serum 5-hydroxy tryptamine (5-HT) concentrations and improvement in clinical symptoms in primary premature ejaculation wit...

Current Pharmacological Management of Premature Ejaculation: A Systematic Review and Meta-analysis.

Premature ejaculation (PE) is the most prevalent male sexual dysfunction. In the last few years, several pharmacologic approaches for oral or topical treatment of PE have been studied.

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement